Patents by Inventor Hemant A. Patel

Hemant A. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process and system for obtaining botulinum neurotoxin
    Patent number: 12241098
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: March 4, 2025
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS
    Publication number: 20250032596
    Abstract: The present disclosure relates to Clostridium botulinum neurotoxin serotype A (BoNT/A) compositions with a plurality of 900 kDa Clostridium botulinum neurotoxin serotype A (BoNT/A) complex species. Provided herein are compositions comprising BoNT/A that have a low level of oxidation at specific methionine positions of 150 kDa BoNT/A.
    Type: Application
    Filed: September 19, 2024
    Publication date: January 30, 2025
    Applicant: AbbVie Inc.
    Inventors: Robert R. Kehrer, Jared Wiig, Hui Xiang, Phillip P. Nguyen, Hemant A. Patel, Connie J. Ng, Cortnie M. Guerrero
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS
    Publication number: 20250032595
    Abstract: The present disclosure relates to Clostridium botulinum neurotoxin serotype A (BoNT/A) compositions with a plurality of 900 kDa Clostridium botulinum neurotoxin serotype A (BoNT/A) complex species. Provided herein are compositions comprising BoNT/A that have a low level of oxidation at specific methionine positions of 150 kDa BoNT/A.
    Type: Application
    Filed: September 19, 2024
    Publication date: January 30, 2025
    Applicant: AbbVie Inc.
    Inventors: Robert R. Kehrer, Jared Wiig, Hui Xiang, Phillip P. Nguyen, Hemant A. Patel, Connie J. Ng, Cortnie M. Guerrero
  • Clostridium botulinum Serotype A Neurotoxin (BoNT/A) Sequence Variants
    Publication number: 20240277820
    Abstract: Provided herein are compositions comprising a Clostridium botulinum neurotoxin serotype A (BoNT/A) complex comprising a 150 kDa BoNT/A. Said 150 kDa BoNT/A is in the form of a plurality of sequence variant species, wherein the plurality of sequence variant species comprises a 150 kDa BoNT/A sequence variant species with a C-terminal truncated light chain.
    Type: Application
    Filed: January 19, 2024
    Publication date: August 22, 2024
    Applicant: AbbVie Inc.
    Inventors: Robert R. Kehrer, Jared Wiig, Hui Xiang, Phillip P. Nguyen, Hemant A. Patel, Connie J. Ng, Cortnie M. Guerrero
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS
    Publication number: 20240245760
    Abstract: The present disclosure relates to Clostridium botulinum neurotoxin serotype A (BoNT/A) compositions with a plurality of 900 kDa Clostridium botulinum neurotoxin serotype A (BoNT/A) complex species. Provided herein are compositions comprising BoNT/A that have a low level of oxidation at specific methionine positions of 150 kDa BoNT/A. Further provided herein are methods of producing a composition comprising BoNT/A using a low temperature during the process of fermenting Clostridium botulinum bacteria.
    Type: Application
    Filed: January 19, 2024
    Publication date: July 25, 2024
    Applicant: AbbVie Inc.
    Inventors: Robert R. Kehrer, Jared Wiig, Hui Xiang, Phillip P. Nguyen, Hemant A. Patel, Connie J. Ng, Cortnie M. Guerrero
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20230029327
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: September 27, 2022
    Publication date: January 26, 2023
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20230021648
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: September 27, 2022
    Publication date: January 26, 2023
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Process and system for obtaining botulinum neurotoxin
    Patent number: 11530400
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: June 8, 2022
    Date of Patent: December 20, 2022
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Process and system for obtaining botulinum neurotoxin
    Patent number: 11525130
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: January 19, 2022
    Date of Patent: December 13, 2022
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Process and system for obtaining botulinum neurotoxin
    Patent number: 11518986
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: March 15, 2022
    Date of Patent: December 6, 2022
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20220298496
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: June 8, 2022
    Publication date: September 22, 2022
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20220251532
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: April 29, 2022
    Publication date: August 11, 2022
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20220228136
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: March 15, 2022
    Publication date: July 21, 2022
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20220204958
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: March 15, 2022
    Publication date: June 30, 2022
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20220145279
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 12, 2022
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Process and system for obtaining botulinum neurotoxin
    Patent number: 11326155
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: May 10, 2022
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20220033796
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 3, 2022
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Process and system for obtaining botulinum neurotoxin
    Patent number: 11203748
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: December 21, 2021
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • Process and system for obtaining botulinum neurotoxin
    Patent number: 11124786
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: September 21, 2021
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad
  • PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
    Publication number: 20200071686
    Abstract: Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
    Type: Application
    Filed: November 4, 2019
    Publication date: March 5, 2020
    Inventors: Jennifer L. Ton, Hemant A. Patel, Ronald C. Bates, Wajdie M. Ahmad